Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 64,643 ELTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 64,643 | n/a |
| Feb 3, 2026 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 25,400 | n/a |
| Feb 4, 2025 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 44,000 | n/a |
| Oct 2, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 28,200 | n/a |
| Feb 5, 2024 | Elicio Therapeutics, Inc. (ELTX) | Grant/Award | 28,200 | n/a |
| Aug 13, 2021 | Surrozen, Inc./DE (SRZN) | Grant/Award | 30,000 | n/a |